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Abstract: Fluorinated substances have outstanding importance in most fields of the chemical 
industry, from agrochemicals and material science to pharmaceutical research. Although aryl- 
and heteroaryl-trifluoroethyl ethers have widespread applications, predominantly as drug 
molecules, their preparation was limited to classical synthetic methodologies until the last 
decade. The transition metal catalyzed cross coupling reactions offered novel synthetic 
approaches for the facile access of trifluoroethoxylated aromatic compounds. The aim of this 
review is to give a good overview on recent advances in the synthesis of aryl-trifluoroethyl ethers 
from a practical point of view for synthetic organic chemists working in the field of 
pharmaceutical industry and academia. 
1. Introduction 
The outstanding importance of fluorine-containing molecules in drug discovery, and other areas 
of the chemical industry, is a well-known, and frequently cited fact.[1] A large number of recent 
reviews dissects the special physico-chemical, metabolic and ADME properties attributed to 
fluorous functional groups and bioisosters.[ 2 ] From a medicinal chemist’s point of view 
monofluorinated-, or trifluoromethylated-arenes[3] consist of the most frequently used molecular 
motifs for the pharmaceutically important compounds. In general, the introduction of these 
fluorous functional groups into aromatic and heteroaromatic cores can be achieved through 
well-established synthetic routes and frequent applications.[4] Moreover, the introduction of other 
biologically relevant promising structural motifs such as fluoroalkoxy groups are more 
challenging synthetic task.[5] In this review, the synthetic approaches of aryl- and heteroaryl-
2,2,2-trifuoroethyl ethers are discussed. 
The importance of this fluoroalkylether function in the field of medicinal chemistry can be 
demonstrated with the large pool of well-known bioactive aryl- or heteroaryl-trifluoroethyl ethers 
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(Scheme 1). Flecainide (antiarrhythmic agent) contains two trifluoroethoxy group on the phenyl 
ring, while Silodosin (used for treatment of benign prostatic hyperplasia) is equipped one 
trifluoroethoxy function on the phenyl ring. In the second group of these bioactive molecules the 
trifluoroethoxy group is attached to pyridine core. Among these heteroaryl trifluoroethyl ethers 
the most known fluorine containing blockbuster pharmaceuticals is Lansoprazole used as proton 
pump inhibitor. 
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 Scheme 1. Illustrious drug molecules, 
containing aryl-trifluoroethyl ethers. 
Besides their widespread industrial 
applications, trifluoroethoxy-arenes gain more 
attention recently and have utilizations also in 
academic research. Njardarson and co-workers 
demonstrated the applicability of trifluoroethoxy 
group as a protected phenolic OH function in 
the total synthesis for vinigrol,[6] a diterpenoid 
with outstanding structural complexity and 
biological activity. 
 
During their synthesis, they used trifluoroethyl 
group as a very stable protecting group for 
alcohols, which can be cleaved with strong 
bases.[7] (Scheme 2) 
 
Scheme 2. Further applications of 
trifluoroethoxy-arenes. 
2. Classical synthetic routes  
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several methods have been developed for 
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Two major retrosynthetic paths are used for the synthesis of the aryl fluoroalkyl ethers. In the 
first approach, C-O bond formation occurs between a phenolic species and a trifluoroethyl 
electrophile synthon, while the other a synthetic option for the formation of C-O bond is the 
reaction of trifluoroalkoxyde synthons with activated aryl species. 
2.1. Reaction of phenols and trifluoroethyl-electrophiles  
An obvious choice for the production of aryl-alkylethers is the Williamson-type synthesis, 
utilizing phenolates and alkyl-electrophiles. Considering the broad availability of hydroxy-arenes 
and heteroarenes this synthetic approach has obvious advantages. However, due to the special 
reactivity and physical properties of fluoroalkyl compounds equipped with any type of leaving 
group, unexpected difficulties may occur during nucleophilic substitutions. For instance, 
trifluoroethyl-halides are highly volatile compounds (the boiling point of 1,1,1-trifluoro-2-
iodoethane is 54.8 °C), which considerably limits their use at elevated temperatures. Additionally, 
these compounds have typically low reactivity as electrophiles,[8] which is attributed to the strong 
electron withdrawing effect of the CF3-group.  
 
Scheme 3. Trifluoroethylation of phenols utilizing trifluoroethyl-halides. 
Also for this reason, trifluoroethyl-electrophiles may show unsatisfactory chemoselectivity in 
substitutions, thus elimination by-products or even reversed selectivity can be observed, which 
means that the leaving group may act as an electrophile. [8a] Thus, besides several applications 
of trifluoroethyliodide,[ 9 ] only few examples can be found for other halides such as 
trilfuoroethylbromide [10] (Scheme 3). Both alkylating agent were used for the O-alkylation of 
phenolic derivatives in polar aprotic solvent at elevated temperature in a sealed reaction vessel 
under basic reaction conditions. 
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To overcome the technical difficulties of the O-alkylation with trifluoroethyl halides, several 
other methods were developed for the 2,2,2-trifluoroethylation of phenol derivatives with the use 
of alternative trifluoroethylating agents (Scheme 4). The most common class of these reagents 
are sulfonates, that possess overall acceptable reactivity with decreased volatility (trifluoroethyl-
triflate, the most reactive and volatile reagent of this group boils at 91 °C). Large-scale, industrial 
applications, as well as small-scale, exploratory research examples exist for the utilization of 
trifluoroethyl-mesylate, -tosylate and -triflate in the synthesis aryl trifluoroethyl ethers.[ 11 ] 
According to the reactivity of these trifluoroethyl synthons trifluoroethyl-triflate can be used for 
the alkylation of phenols below 100 °C, other sulfonates usually require much higher 
temperatures, which could limit the functional group tolerance of a transformation in case of 
sensitive compounds. 
Hypervalent iodonium salts can also serve as trifluoroethyl-electrophiles, as shown by 
Umemoto et al.[12] The iodonium super leaving group attached to the trifluoroethyl group makes 
this species highly reactive towards heteroatom nucleophiles even at low temperature, and 
ensures shorter reaction times compared to the former reagents. 
 
Scheme 4. Trifluoroethylation of phenols with various electrophiles. 
Although economic considerations might not make aryl-trifluoroethyl iodonium triflates the 
best option, selective transformation of sensitive molecules can justify their application. 
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Similarly, recent studies show, that 2,4,6-tris-(2,2,2-trifluoroethoxy)-[1,3,5] triazene, or 
PhenoFluor reagent can also be applied for the trifluoroethylation of phenol derivatives, and 
provide the desired trifluoroethylethers in good yield under ambient reaction conditions.[13] 
2.2. Aromatic nucleophilic substitutions  
In spite of the reduced nucleophilic character of trifluoroethanol,[14] the aromatic nucleophilic 
substitution approach for the synthesis of trifluoroethoxylated pharmaceuticals is quite common 
and have remarkable industrial background. Considering the nature of aromatic nucleophilic 
substitution, the substrate scope of SNAr reactions are rather limited to electron poor aromatic 
compounds. Fluorine, chlorine or nitro group are applicable as leaving group and generally 
elevated temperature is required to the achievement of the transformation. 
An early example of trifluoroethoxylation through nucleophilic substitution of chloroarenes 
well represents the characteristics of this type of reaction (Scheme 5).[15] Electron deficient 
aromatic chlorides underwent substitution in HMPA at elevated temperature with sodium salt of 
trifluoroethanol providing the desired ethers in good yields. 
  
Scheme 5. Transformation of electron deficient chloroarenes to trifluoroethyl-ethers in SNAr 
reaction 
Switching to more reactive starting materials, fluoro- and nitroarenes, the reaction 
temperature could be drastically reduced (Scheme 6).[16] However, the efficient procedure still 
requires the presence of the strong electron withdrawing groups in orto- and para-positions to 
the leaving group. 
 
Scheme 6. Trifluoroethoxylation of electron poor nitro- and fluoroarenes in SNAr reactions 
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Regarding to pharmaceutical applications, introduction of the 2,2,2-trifluoroethoxy-moiety 
takes place through the replacement of a nitro-group or a halogen in several notable examples 
(Scheme 7).[17] Despite the simplicity and effectiveness, the known safety risks related to this 
reaction route is also worth to mention and take into account during the plan and design of 
synthetic sequence, especially on industrial scale.[18] 
 
Scheme 7. Applications of aromatic nucleophilic substitution in medicinal chemistry. 
3. Transition-metal mediated trifluoroethoxylations 
Although procedures mentioned in previous section represent well-established synthetic 
methodologies for certain challenges, universally applicable reactions for the preparation of 
trifluoroethoxy-arenes were absent until the last decade. In the last few years, transition metal 
catalyzed C-O bond forming reactions underwent rapid and efficient developments,[19] and 
several new transformations became available for the efficient synthesis of the desired ether 
species. Thus, with novel, efficient and selective catalytic systems, most of the challenges in 
the field of fluoroalkoxylation of aryl-halides were addressed. 
3.1. Transformations of aryl-iodides  
Considering the existing C-O bond forming cross-coupling reactions, it can be concluded, 
that replacement of an iodine atom by an alkoxide is best supported by copper catalysis. The 
first example for copper-mediated displacement of iodine to form aryl-trifluoroethyl ethers was 
described in 1985, by A. Osuka and co-workers.[20] With the applied conditions, unactivated 
iodobenzenes bearing electron donating groups, such as methyl and methoxy, were converted 
to trifluoroethyl ethers. Moderate to good yields were achieved, applying 2 equivalents of 
copper-iodide (Scheme 8). While chloroarenes remained completely inactive, aryl bromides 
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reacted sluggishly (less, than 30 % conversion after 12 hours) under these reaction conditions, 
making iodoarenes the only viable option as substrates. 
 
Scheme 8. Copper-catalyzed trifluoroethoxylation of aryl-iodides. 
While several attempts were made in the meantime, it was more than two decades later, 
when Vuluga and co-workers published the first, widely applicable catalytic system for the 
trifluoroethoxylation of aryl iodides (Scheme 9).[21] In this reaction, iodoarene starting materials 
are reacted with large excess of 2,2,2-trifluoroethanol (used as solvent) in the presence of 
Cs2CO3 base, catalytic CuI and an inexpensive keto-ester ligand. Similarly to previous findings, 
aryl bromides reacted less readily (when both halogens were present, iodine was displaced first), 
and chlorides were completely inactive with the given conditions.  
 
Scheme 9. Copper-catalyzed trifluoroethoxylation of aryl-iodides and bromides. 
3.2. Transformations of aryl bromides 
While aryl iodides are predominantly converted to the desired ethers by copper catalysis, 
transformation of bromoarenes can be achieved by copper and palladium catalysis as well. 
Usually, the former being a more economic, while the latter catalytic method provides a more 
specific and selective choice. Transformation of aryl bromides are more challenging, but also 
more advantageous than aryl iodides, since their price and availability makes them the preferred 
starting material.  
The first example for catalytic displacement of bromine to form aryl-trifluoroethyl ether was 
described in 1992, by M. A. Keegstra and co-workers. (Scheme 10).[22] In the early and simple 
protocol, NMP ensures good reaction medium for the CuI-catalyzed alkoxylation of 
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bromobenzene. However, harsh conditions did not allow the transformation of flexibly 
functionalized haloarenes. 
 
Scheme 10. Copper-catalyzed trifluoroethoxylation of bromobenzene. 
In 2011, almost 20 years later, S. L. Buchwald and co-workers developed an efficient, 
palladium catalyzed etherification reaction.[23]  
 
Scheme 11. Cross-coupling reaction of aryl-halides and primary alcohols mediated by 
palladacycle catalyst. 
This publication describes the functionalization of variously substituted aryl- and heteroaryl 
bromides and chlorides with different primary and secondary alcohols. The coupling reaction 
was achieved by a special, bulky and electron rich phosphine ligand, RockPhos. Among many 
examples for alkoxylations with different aliphatic alcohols, the trifluoroethoxylation of a 
substrate was also described as the part of the substrate scope of the developed methodology 
(Scheme 11, a). 
In 2018, the same research group disclosed the further study on efficient ligands for palladium 
catalyzed ether synthesis.[24] In this work, extensive examination and optimization of catalysts 
was carried out, in order to find an efficient and selective method for functionalization of diverse, 
sometimes unactivated aryl-bromides and chlorides with primary alcohols (Scheme 11, b). 
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Prasad and co-workers described the transformation of electron-poor aryl halides to 
fluoroalkylethers, mainly trifluoroethoxides in 2014. This method features an established 
catalytic system, consisting of a stable Pd(0)-source and a bulky, dialkyl-biphenyl phosphine 
ligand, BrettPhos, which was developed by the laboratory of S. L. Buchwald. In this study, 
conversion of highly activated bromoarenes was straightforward, however less electron poor 
bromides performed poorly, while aryl chlorides only underwent trifluoroethoxylation when 
strong electron-withdrawing groups were present in para- or orto-position. (Scheme 12). [25] 
 
Scheme 12. Palladium catalyzed trifluoroethoxylation of electron deficient aryl bromides. 
In 2015, Weng and co-workers described a copper-mediated trifluoroethoxylation with 
excellent functional group tolerance, and good selectivity (Scheme 13).[26] Electron-rich and –
poor substrates, as well as sterically-hindered and heteroaromatic bromides were transformed 
in good or excellent yields utilizing a novel, copper-containing trifluoroethoxy-source. 
 
Scheme 13. Stoichiometric copper-mediated trifluoroethoxylation of bromoarenes. 
In 2015, MacMillan et al. described a mechanistically fascinating, photocatalytic method for 
C-O bond formation (Scheme 14).[ 27 ] In this study, substrates were mostly activated aryl 
bromides, which were converted with good or excellent yields to the corresponding alkoxy 
arenes with the aid of five different catalysts and additives, and the presence of blue light. 
Scheme 14. Photocatalyzed 
trifluoroethoxylation of aryl-bromides. 
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3.3. Transformations of aryl chlorides 
The cross-coupling etherification of aryl chlorides is even less frequent, than the 
transformation of bromides, and contains exclusively palladium catalyzed reactions. As 
mentioned above, trifluoroethoxylation of certain chloroarenes is possible in palladium catalyzed 
reactions described by the Buchwald group.[22,23] Also, it was shown that electron deficient aryl-
chlorides underwent trifluoroethoxylation in similar conditions, with less specialized catalytic 
system.[25]  
However, a widely applicable process deliberately for transforming aryl chlorides to the 
corresponding trifluoroethyl ethers was absent until 2017, when it was developed by our 
research group (Scheme 15).[28] Similarly to other C-O bond forming cross-coupling reactions, 
1 mol% Pd2dba3, a dialkyl-biphenyl phosphine ligand, tBuXPhos was necessary for efficient 
reaction. The alkoxy-source in this method is not the alcohol itself, but a tetravalent borate salt, 
containing trifluoroethoxy groups. The utilization of borate salts in C-O bond forming coupling 
reactions was developed previously by our research group, and it makes the utilization of an 
external base unnecessary. [29] As a consequence of this feature, base sensitive molecular 
motifs were well tolerated during the reaction, and several aryl and heteroaryl trifluoroethyl 
ethers were isolated after the coupling reactions. 
 
Scheme 15. Trifluoroethoxylation of aryl-chlorides utilizing a borate salt. 
As the demonstration of the synthetic power of the borate based palladium catalyzed 
trifluoroethoxylation reaction, the synthesis of a fluorous analog of Sildenafil was carried out 
also. During the synthetic route, it was shown that the cross coupling can be achieved on an 
aryl chloride bearing aldehyde- sulfonamide- and tertiary amine functions as well. 
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Scheme 16. Utilization of the borate based, palladium catalyzed trifluoroethoxylation for the 
synthesis of the fluorous analog of Sildenafil 
Completion of the synthetic sequence provided the fluorous analog of Silednafil which was 
ready for in vitro evaluation. The comparison of physico-chemical and ADME properties of the 
original drug substance and the fluorinated derivative showed the expected differences which 
are usually attributed to fluorinated pharmaceuticals. 
3.4. Trifluoroethoxylation through oxidative processes 
Besides aryl halides, several different starting materials have also emerged for the 
preparation of aryl trifluoroethyl ethers. In 2003, a Chan-Evans-Lam type transformation of aryl-
trifluoroborate salts and aliphatic alcohols to the corresponding ethers was described.[30] The 
reaction proceeds at room temperature, under O2 atmosphere, in the presence of 4 Å molecular 
sieves, Cu(OAc)2 catalyst and 4-(dimethylamino)pyridine ligand. In the substrate scope, among 
the introduction of many different alkoxy-groups, one example for trifluoroethoxylation was 
reported with good yield (Scheme 17).  
 
Scheme 17. Copper-catalyzed oxidative alkoxylation of organotrifluoroborates. 
On the other hand, later developments by Wu[31] and Qing et al.[32] described very similar 
reaction conditions to previous methods for the facile synthesis of aryl trifluoroethylethers. Their 
methodologies are based on the use of Cu(OAc)2 catalyst, pyridine-type base and oxidative 
atmosphere. (Scheme 18 a and b respectively). Under these circumstances, a large variety of 
aryl- and heteroarylboronic acids were trifluoroethoxylated, and the target products were 
isolated in 50-60% yield range. 
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Scheme 18. Trifluoroethoxylation of arylboronic acids in Chan-Evans-Lam type reactions. 
In 2017, a palladium-catalyzed trifluoroethoxylation through C-H activation of 
N‑Sulfonylbenzamides was published by Li and co-workers (Scheme 19).[33]  
 
Scheme 19. Palladium catalyzed trifluoroethoxylation through C-H activation. 
The ortho-selective transformation requires 10% Pd(OAc)2 catalyst, large excess of 
trifluoroacetic acid and trifluoroethanol and stoichiometric amount of oxidant, PhI(OAc)2, and 
provided the trifluoroethoxy-substituted N-sulphonylbenzamides in 50-60% yields. 
An oxidative trifluoroethoxylation of acetanilides was reported this year by Mal et al.[34] In this 
process, trifluoroethoxy group is introduced in the para-position by an SEAr-type oxidative 
functionalization of C-H bonds. The reaction setup is quite simple, does not require transition-
metal catalysts, and several derivatives were prepared under mild reaction conditions in the 
range of 25-77% yield (Scheme 20). 
 
Scheme 20. Oxidative C-H bond trifluoroethoxylation of anilides 
4. Summary and outlook 
In summary, synthetic tools based on transition metal catalyzed trifluoroethoxylation of 
aromatic and heteroaromatic molecules provide novel approach to trifluoroethyl arylethers. The 
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existing and discussed C-O bond formations through cross coupling or C-H activation ensure 
efficient syntheses for the target compounds, which generally have importance from the aspects 
of medicinal chemistry. These methodologies could have widespread application in the 
synthesis of biologically active molecules having trifluoroethoxy group, and further 
developments in the future. 
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